In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrel.

Journal Article (Journal Article)

Navarese EP, Khan SU, Kolodziejczak M, et al. Comparative efficacy and safety of oral P2Y 12 inhibitors in acute coronary syndrome: network meta-analysis of 52 816 patients from 12 randomized trials. Circulation. 2020;142:150-60. 32468837.

Full Text

Duke Authors

Cited Authors

  • Nanna, MG; Granger, CB

Published Date

  • October 20, 2020

Published In

Volume / Issue

  • 173 / 8

Start / End Page

  • JC44 -

PubMed ID

  • 33075264

Electronic International Standard Serial Number (EISSN)

  • 1539-3704

Digital Object Identifier (DOI)

  • 10.7326/ACPJ202010200-044

Language

  • eng

Conference Location

  • United States